Gastroesophageal Reflux Disease Devices Market Expands with Minimally Invasive Care by 2036
Author : priya patil | Published On : 14 Jul 2026
According to the latest analysis by Future Market Insights (FMI), the global gastroesophageal reflux disease (GERD) devices market is witnessing steady expansion as healthcare providers increasingly adopt advanced diagnostic and therapeutic technologies for reflux management. The growing burden of GERD worldwide, coupled with rising awareness regarding early diagnosis and effective treatment, continues to support demand for innovative medical devices across hospitals, diagnostic centers, and ambulatory surgical facilities.
The market is benefiting from significant advancements in endoscopic technologies, pH monitoring systems, manometry devices, magnetic sphincter augmentation systems, and minimally invasive fundoplication procedures.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-1741
Market Growth Path
The global gastroesophageal reflux disease (GERD) devices market is projected to grow from USD 1.3 billion in 2026 to approximately USD 1.9 billion by 2036, registering a CAGR of 3.9% during the forecast period.
The market is expected to generate an incremental opportunity of nearly USD 600 million over the next decade, supported by increasing demand for advanced reflux diagnostics, expanding adoption of minimally invasive treatment procedures, and growing investments in gastrointestinal healthcare infrastructure.
Market Overview
Gastroesophageal reflux disease devices comprise a broad range of diagnostic and therapeutic systems used to evaluate, monitor, and manage chronic acid reflux disorders. These devices include esophagoscopes, gastroscopes, pH monitoring systems, manometry systems, fundoplication devices, sphincter augmentation systems, and radiofrequency ablation technologies.
As the prevalence of GERD continues to rise globally due to changing dietary habits, obesity, aging populations, and sedentary lifestyles, healthcare providers are increasingly utilizing advanced diagnostic and treatment devices to improve patient outcomes while reducing long-term complications associated with chronic reflux disease.
Key Growth Drivers
Increasing incidence of GERD worldwide remains one of the primary drivers supporting market growth. Growing awareness regarding reflux-related complications such as Barrett’s esophagus and esophageal cancer is encouraging earlier diagnosis and intervention.
The expanding use of endoscopic examinations and reflux monitoring technologies is creating sustained demand for diagnostic devices. In addition, increasing adoption of minimally invasive treatment options is supporting the growth of therapeutic device categories.
Technology & Innovation Trends
Technological innovation continues to transform the GERD devices market through the development of advanced endoscopic imaging platforms, high-resolution manometry systems, wireless pH monitoring devices, and implantable reflux management technologies.
Manufacturers are increasingly focusing on minimally invasive solutions that offer reduced recovery times, improved procedural outcomes, and enhanced patient comfort. Magnetic sphincter augmentation systems and next-generation fundoplication devices are gaining attention as alternatives to long-term pharmaceutical therapies.
Market Challenges & Restraints
Despite favorable growth prospects, the GERD devices market faces several challenges.
High procedure costs associated with advanced reflux management devices may limit adoption in cost-sensitive healthcare systems. Reimbursement complexities and varying regulatory requirements across regions can also create barriers to market expansion.
Additionally, patient preference for pharmaceutical therapies, limited awareness regarding advanced treatment options, and the need for specialized clinical expertise may affect device adoption rates in certain markets.
Segment Analysis
Based on product type, the market is segmented into esophagoscopes & gastroscopes, diagnostic devices, manometry systems, pH monitoring systems, treatment devices, fundoplication devices, sphincter augmentation devices, and radiofrequency ablation devices.
Esophagoscopes and gastroscopes continue to dominate the market, accounting for approximately 42% of revenue share in 2026, owing to their critical role in first-line diagnosis and assessment of reflux-related disorders.
By procedure type, the market includes diagnostic procedures, fundoplication procedures, radiofrequency thermal ablation, and magnetic sphincter augmentation.
Fundoplication procedures are expected to account for nearly 35% of procedure demand, reflecting their continued importance in managing severe and treatment-resistant GERD cases.
Based on end users, hospitals remain the leading segment with approximately 60% market share, supported by comprehensive diagnostic capabilities, specialized gastroenterology departments, and access to advanced treatment technologies.
Regional Analysis
North America continues to represent a major market for GERD devices, supported by high disease prevalence, advanced healthcare infrastructure, strong reimbursement systems, and widespread adoption of minimally invasive gastrointestinal procedures.
Europe maintains steady growth owing to increasing awareness regarding reflux-related complications, expanding access to diagnostic technologies, and rising adoption of advanced treatment systems.
Asia Pacific is expected to register significant growth throughout the forecast period, driven by improving healthcare infrastructure, growing hospital investments, rising disease awareness, and expanding access to gastrointestinal diagnostics. India and China continue to emerge as important growth markets due to increasing healthcare modernization initiatives and expanding endoscopy capacity.
Latin America and the Middle East & Africa are also expected to experience gradual market expansion as healthcare access improves and investments in specialized gastrointestinal care continue to increase.
Competitive Landscape
The global GERD devices market remains moderately competitive, with manufacturers focusing on technological innovation, product differentiation, strategic collaborations, and geographic expansion.
Companies are investing heavily in advanced endoscopy platforms, reflux monitoring technologies, minimally invasive treatment devices, and physician training programs to strengthen their market position.
Leading market participants include Olympus Corporation, Fujifilm Holdings Corporation, PENTAX Medical, KARL STORZ SE & Co. KG, Johnson & Johnson MedTech,
